Biggest News Aggregation in the World
๐Ÿ“ฐ Future Trials News

Future Trials News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Future Trials. Real-time updates on events, politics, business and more.

Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months -March 26, 2024 at 08:31 am EDT

JERUSALEM, March 26, 2024 -- Entera Bio Ltd. , a leader in the development of orally delivered peptides, announced today that The American Society for Bone and Mineral Research announced on March...
Israel General United States Miranda Toledano Laura Calvi Entera Bio Ltd Pamerican Society For Bone

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science